Homebiotech

biotech

biotech

Thalassaemia treatment gets EU approval

Jim Cornall - May 27, 2026

biotech

New data from Parkinson’s disease trial

Jim Cornall - May 27, 2026

biotech

Restoring the “longevity protein”

Jim Cornall - May 27, 2026

biotech

Positive topline results from phase 2 recurrent ovarian cancer trial

Jim Cornall - May 26, 2026

biotech

Valthos raises $30m to build next-generation biodefence

Jim Cornall - November 5, 2025

biotech

CAR-T therapy in Korea

Jim Cornall - November 5, 2025

biotech

Myrio Therapeutics to work with research institutions on solid tumour T-cell immunotherapeutics

admin - November 4, 2025

biotech

Positive topline results for frontotemporal degeneration treatment

Jim Cornall - November 4, 2025

biotech

Lilly and NVIDIA building industry’s most powerful AI supercomputer

Jim Cornall - November 4, 2025

biotech

New findings pave the way for ear infection vaccine

Jim Cornall - November 3, 2025

biotech

Immune checkpoint inhibitors promote tissue repair

Jim Cornall - November 3, 2025

biotech

Base to Base biotech podcast 33: Pain relief, fungi and psychedelics

Jim Cornall - October 31, 2025

1...434445...79 Page 44 of 79

Stay Connected

- Advertisement -

spot_img

Latest Articles

biotech

Thalassaemia treatment gets EU approval

Jim Cornall - May 27, 2026 0

Agios Pharmaceuticals, Inc. has revealed that the European Commission has granted marketing authorisation for PYRUKYND (mitapivat), an oral pyruvate kinase (PK) activator, in adults...

New data from Parkinson’s disease trial

biotech Jim Cornall - May 27, 2026 0

Restoring the “longevity protein”

biotech Jim Cornall - May 27, 2026 0

Positive topline results from phase 2 recurrent ovarian cancer trial

biotech Jim Cornall - May 26, 2026 0

Rare oral cancer has distinct genetic profile

biotech Jim Cornall - May 26, 2026 0